节点文献

培哚普利、非洛地平缓释片对老年原发性高血压患者血小板活化及纤溶活性的影响

The effect of perindopril and felodipine extended release tablets on platelet activation and fibrinolytic activity in elderly patients with essential hypertension

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 邹广涛; 王明银; 马志敏; 田其生;

【Author】 Zou Guangtao  Wang Mingyin  Ma Zhimin et al ( Department of Internal Medicine, Zhoukou Prefecture People′s Hospital, Zhoukou 466000)

【机构】 周口地区人民医院内科!河南周口; 466000; 周口纺织医院内科;

【摘要】 目的:探讨培哚普利及非洛地平缓释片对老年原发性高血压( E H)患者血小板活化及纤溶活性的影响。方法:采用放射免疫法及发色底物法测定55例老年Ⅰ、Ⅱ期 E H 患者分别应用培哚普利(Ⅰ组28例)及非洛地平缓释片(Ⅱ组27例)治疗前后活化血小板α颗粒膜蛋白( G M P140)、组织型纤溶酶原激活剂(t P A)及其抑制物( P A I1)、血管紧张素Ⅱ( AngⅡ)及醛固酮( Ald)水平。结果:治疗后,两组患者 G M P140含量及 P A I1活性均显著下降( P 分别< 0.01,0.05),t P A 活性显著升高( P < 0.05);Ⅰ组患者 AngⅡ及 Ald 显著下降( P < 0.01),Ⅱ组患者 AngⅡ及 Ald 未见明显变化( P > 0.05)。治疗前,55例 E H 患者 G M P140 含量与 P A I1水平呈显著正相关( r =0.407 6, P < 0.01),二者与 AngⅡ水平均呈显著正相关( r = 0.416 2,0.4237, P < 0.01)。结论:以上结果提示,培哚普利降低体内 AngⅡ水平是其抑制老年 E H 患者血小板活化、改善纤溶活性的机制之一,而非洛地平缓释片抑制血小板活化、改善纤溶?

【Abstract】 Objective:To evaluate the effect of perindopril and felodipine extended release tablets on platelet activation and fibrindytic activity in elderly hypertensives.Method:Radioimmunoassay and spectrophotometric assay were used to examine the levels of platelet alpha granule membrane protein (GMP 140), tissue type plasminogen activator (t PA) and its inhibitor (PAI 1), angiotensinⅡ(ANGⅡ) and aldosterone (Ald) after treatment with perindopril (group Ⅰ,n=28) and felodipine extended release tablets (group Ⅱ,n=27) in 55 elderly patients with essential hypertension (EH) of stage Ⅰ to Ⅱ. Result:After treatment, GMP 140 and PAI 1 activity significantly reduced (P< 0.01 , 0.05 respectively), but t PA activity significantly increased (P< 0.05 ) in both group. AngⅡ and Ald significantly reduced (P< 0.01 ) in group Ⅰ. No obvious changes of Ang Ⅱ and Ald were found in group Ⅱ. Before treatment, a positive correlation was noted between the levels of GMP 140 and PAI 1 (r= 0.407 6 ,P< 0.01 ),GMP 140 and AngⅡ(r= 0.416 2 ,P< 0.01 ),as well as PAI 1 and AngⅡ(r= 0.423 7 ,P< 0.01 ) in the 55 EH patients.Conclusion:These findings indicate that decreasing the levels of AngⅡ is one of the mechanism of perindopril to inhibit platelet activation and to improve fibrinolytic activity in elderly EH patients,but the effect of felodipine extended release tablets to inhibit platelet activation and to improve fibrinolytic activity has no relation to renin angiotensin system.

  • 【文献出处】 临床心血管病杂志 ,JOURNAL OF CLINICAL CARDIOLOGY , 编辑部邮箱 ,1999年08期
  • 【分类号】R544.1
  • 【被引频次】14
  • 【下载频次】36
节点文献中: 

本文链接的文献网络图示:

本文的引文网络